You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Suppressed

Showing 1 - 25 of 1,354
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Virologically Suppressed People Living With HIV and Factors

Completed
  • HIV Infections
  • dual therapy
  • Tourcoing, France
    Centre Hospitalier DRON
Oct 30, 2023

Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)

Not yet recruiting
  • Chronic Hepatitis B
  • HRS9950 tablets
  • HRS9950 placebo tablets
  • (no location specified)
Jun 7, 2023

HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

Not yet recruiting
  • HIV Infections
  • Teropavimab
  • +4 more
  • (no location specified)
Feb 6, 2023

Switch From Etravirine to Doravirine asPart of Antiretroviral

Not yet recruiting
  • HIV Infections
    • (no location specified)
    Nov 24, 2023

    Lactation Suppressed, Second Trimester Abortion Trial in Chicago (Cabergoline, Placebo)

    Not yet recruiting
    • Lactation Suppressed
    • Second Trimester Abortion
    • Chicago, Illinois
      Northwestern Medical Center
    Nov 7, 2023

    HIV Trial in Barcelona (Biktarvy 50 mg/200 mg/25 mg film-coated tablets)

    Not yet recruiting
    • HIV Infections
    • Biktarvy 50 mg/200 mg/25 mg film-coated tablets
    • Barcelona, Spain
      Hospital Clinic i Provincial Barcelona
    Oct 26, 2022

    HIV I Infection Trial in Orlando (Dolutegravir / Lamivudine Pill, Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill)

    Active, not recruiting
    • HIV I Infection
    • Dolutegravir / Lamivudine Pill
    • Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill
    • Orlando, Florida
      Orlando Immunology Center
    Sep 20, 2022

    HIV-1 Infection Trial (ART, DOR/ISL)

    Not yet recruiting
    • HIV-1 Infection
    • (no location specified)
    Jan 4, 2023

    HIV-1-infection Trial (Fostemsavir 600 MG [Rukobia])

    Recruiting
    • HIV-1-infection
    • Fostemsavir 600 MG [Rukobia]
    • Orlando, Florida
      Orlando Immunology Center
    Sep 20, 2022

    Microbiota Footprint and Frailty Phenotype in Virologically

    Not yet recruiting
    • HIV Infections
    • Stool sampling
    • +2 more
    • Marseille, France
      Hôpital Européen Marseille
    Jul 26, 2022

    HIV-1-infection Trial in Barcelona (Doravirine 100Mg Tab)

    Not yet recruiting
    • HIV-1-infection
    • Doravirine 100Mg Tab
    • Barcelona, Spain
      Hospital Clinic i Provincial de Barcelona
    Aug 17, 2022

    HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

    Recruiting
    • HIV-1-infection
    • B/F/TAF
    • TDF-based triple ART regimen switching to B/F/TAF
    • Shanghai, Shanghai, China
    • +2 more
    Dec 1, 2022

    Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)

    Not yet recruiting
    • Lactation Suppressed
    • Cabergoline 1 MG
    • Placebo
    • Stanford, California
      Stanford University
    Sep 1, 2023

    HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)

    Not yet recruiting
    • HIV-1 Infection
    • (no location specified)
    Dec 19, 2022

    Human Immunodeficiency Virus Trial in Newark (Dolutegravir/Lamivudine)

    Active, not recruiting
    • Human Immunodeficiency Virus
    • Newark, New Jersey
      Saint Michael's Medical Center
    May 3, 2022

    HIV Trial (Dolutegravir/Rilpivirine FDC)

    Not yet recruiting
    • HIV Infections
    • Dolutegravir/Rilpivirine FDC
    • (no location specified)
    Jan 5, 2023

    HIV-1-infection Trial in Puerto Rico, United States (TMB-365/TMB-380)

    Recruiting
    • HIV-1-infection
    • San Francisco, California
    • +6 more
    Oct 25, 2022

    HIV Trial in Roma (Antiviral Agents)

    Not yet recruiting
    • HIV Infections
    • Antiviral Agents
    • Roma, Italy
      Fondazione PoliclinicoAgostino Gemelli IRCCS
    Feb 9, 2023

    HIV Trial (Sulforaphane, Placebo)

    Not yet recruiting
    • HIV Infections
    • (no location specified)
    Feb 3, 2022

    Lactation Suppressed Trial in Afula (Cabergoline, Pyridoxine)

    Completed
    • Lactation Suppressed
    • Afula, Israel
      HaEmek Medical Center
    Nov 10, 2022

    HIV-1 Trial in Panama, South Africa, United States (F/TAF, 3rd ARV agent, Boosted PIs)

    Active, not recruiting
    Has Results
    • HIV-1
    • Los Angeles, California
    • +7 more
    Nov 11, 2022

    HIV-1-infection Trial in San Francisco (PRO 140 350, PRO 140 525, PRO 140 700)

    Active, not recruiting
    • HIV-1-infection
    • PRO 140 350
    • +2 more
    • San Francisco, California
      Quest Clinical Research
    Mar 4, 2022

    HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

    Active, not recruiting
    Has Results
    • HIV-1 Infection
    • Doravirine, Tenofovir, Lamivudine
    • +4 more
    • (no location specified)
    Sep 2, 2022

    HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

    Terminated
    • HIV-1-infection
    • Biktarvy Tab
    • Saint Louis, Missouri
      Southampton Healthcare, Inc.
    Jan 3, 2023

    HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)

    Recruiting
    • HIV Vaccine
    • HIV-1-infection
    • C62
    • +4 more
    • Chapel Hill, North Carolina
    • +1 more
    Oct 27, 2022